Bacterial Meningitis Overview

Save information for later
Sign Up

Learn About Bacterial Meningitis

What is the definition of Bacterial Meningitis?
Bacterial meningitis is a serious disease characterized an inflammation of fluid and membranes (meninges) surrounding the brain and spinal cord. Bacterial meningitis can be caused by several types of bacteria, such as Streptococcus pneumoniae, Group B Streptococcus, Neisseria meningitidis, Haemophilus influenzae, and Listeria monocytogenes, as well as sinus and ear infections. While most people recover from bacterial meningitis, the disease can be fatal and cause permanent disabilities, such as brain damage, hearing loss, and learning disabilities.
What are the symptoms of Bacterial Meningitis?
Symptoms of bacterial meningitis include a sudden onset of fever, headache, and a stiff neck. Other symptoms of bacterial meningitis may include lack of appetite, nausea, vomiting, sensitivity to light (photophobia), excessive sleepiness, and confusion. Symptoms of bacterial meningitis in newborns and infants may include high fever, lethargy, difficulty waking, irritability, constant crying, vomiting, poor feeding, and a bulging fontanelle (soft spot on head). Late symptoms of bacterial meningitis may include seizures and coma.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Bacterial Meningitis?
Bacterial meningitis can be fatal and should be treated early. Treatment for bacterial meningitis may include intravenous antibiotics and corticosteroids to prevent serious complications, such as seizures and coma. Drainage of any infected sinuses or mastoids (bones behind outer ear) may also be required.
Who are the top Bacterial Meningitis Local Doctors?
Diederik J. Van De Beek
Elite in Bacterial Meningitis
Diederik J. Van De Beek
Elite in Bacterial Meningitis
Diederik J. Van De Beek
Amsterdam, NH, NL 

Diederik Van De Beek practices in Amsterdam, Netherlands. Van De Beek is rated as an Elite expert by MediFind in the treatment of Bacterial Meningitis. Their top areas of expertise are Bacterial Meningitis, Meningitis, Pneumococcal Meningitis, Thrombectomy, and Tissue Biopsy.

Matthijs C. Brouwer
Elite in Bacterial Meningitis
Matthijs C. Brouwer
Elite in Bacterial Meningitis
Matthijs C. Brouwer
Amsterdam, NH, NL 

Matthijs Brouwer practices in Amsterdam, Netherlands. Mr. Brouwer is rated as an Elite expert by MediFind in the treatment of Bacterial Meningitis. His top areas of expertise are Bacterial Meningitis, Meningitis, Brain Abscess, Thrombectomy, and Tissue Biopsy.

 
 
 
 
Learn about our expert tiers
Learn More
Ray Borrow
Elite in Bacterial Meningitis
Ray Borrow
Elite in Bacterial Meningitis
Ray Borrow
Manchester Royal Infirmary Oxford Road, 
Manchester, ENG, GB 

Ray Borrow practices in Manchester, United Kingdom. Mr. Borrow is rated as an Elite expert by MediFind in the treatment of Bacterial Meningitis. His top areas of expertise are Meningitis, Tetanus, Bacterial Meningitis, Strep Throat, and Splenectomy.

View All Doctors
What are the latest Bacterial Meningitis Clinical Trials?
DIRECT: Doxycycline Adjunctive Therapy to Reduce Excess Mortality and Complications From Central Nervous System Tuberculosis - Phase II Randomized Clinical Trial
DIRECT: Doxycycline Adjunctive Therapy to Reduce Excess Mortality and Complications From Central Nervous System Tuberculosis - Phase II Randomized Clinical Trial
Enrollment Status: Recruiting
Publish Date: August 27, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: Although tuberculosis is now considered a treatable disease, central nervous system tuberculosis (CNS-TB) when managed with the current standard-of-care (SOC), still has mortality rates ranging from 30-50% even in tertiary hospital centers. At present, the SOC for the management of CNS-TB is anti-tuberculous therapy with adjunctive corticosteroids. In CNS-TB, the activity of pathogenic host matrix...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 4, Single-arm, Open-label, Multi-center Study to Assess the Immune Response and Safety of the Meningococcal Group B Vaccine MenB+OMV NZ When Administered to Healthy Infants From 2 Months of Age in the Republic of Korea
A Phase 4, Single-arm, Open-label, Multi-center Study to Assess the Immune Response and Safety of the Meningococcal Group B Vaccine MenB+OMV NZ When Administered to Healthy Infants From 2 Months of Age in the Republic of Korea
Enrollment Status: Recruiting
Publish Date: August 07, 2025
Intervention Type: Biological
Study Phase: Phase 4

Summary: The purpose of this study is to assess the safety and immune responses of rMenB+OMV NZ vaccine when administered to healthy infants from 2 months in the Republic of Korea according to a 2-dose primary schedule and 1 booster dose.

View All Clinical Trials